Deemed revolutionary in a pandemic-struck world, peritoneal dialysis (PD) has cemented itself as the optimum alternative to hemodialysis. The otherwise cost-efficient alternative to the tedious procedure that hemodialysis entails has yet to gain as much traction as it deserves. However, that trajectory flipped overnight when the pandemic struck, and quarantine became an addition to the plethora of hindrances for many dialysis-seeking patients. The Ministry of Health and Family Welfare, Government of India, states that under Pradhan Mantri National Dialysis Program, 2.2 lakh new patients have been added annually in India.
This amounts to 20 crore CKD patients, increasing the yearly dialysis demand of 3.4 crore. A rapid increase in the need for dialysis due to added patients accounts for adopting a more straightforward and feasible treatment option, hence, PD. A few reasons behind the finite growth of PD-despite being available in the country for over two decades-can be economic factors, inadequate government policies, nephrologist bias, and lack of adequate pre-dialysis care. Despite the high number of patients initiating therapy, many early dropout cases have been observed. Early dropouts become even more alarming, considering the impact of COVID-19.
The challenges involved
Diese Geschichte stammt aus der January 2023-Ausgabe von Healthcare Radius.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der January 2023-Ausgabe von Healthcare Radius.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Dengue-related searches surge on Justdial
Justdial data reveals significant increase in dengue-related searches and pest control services this monsoon season, amid severe dengue outbreak in India.
Ipca launches NovaLead's Diulcus for diabetic foot ulcer
Ipca Laboratories launches NovaLead's patented drug Diulcus, for the treatment of diabetic foot ulcer in India.
Sahyadri Hospitals unveils advanced radiotherapy treatment
Sahyadri Hospitals launches Asia's first advanced radiotherapy treatment, Radixact X9 system with Vital Hold technology for precise cancer treatment.
Complex liver transplant saves diabetic patient
Wockhardt Hospitals, Mumbai Central and South Asian Liver Institute provide liver transplant services to a Botswanian patient.
Gynecological cancers rise in young Indian women
Experts stress need for awareness, early screening, and advanced treatment options like robotic-assisted surgery for gynecological cancers.
Mahajan Imaging, Siemens unveil AI diagnostic analyzer
Mahajan Imaging and Labs and Siemens Healthineers launch India's first Al-diagnostic analyzer.
Nimotuzumab boosts head and neck cancer survival - Tata Memorial study
A Tata Memorial study finds Nimotuzumab increases 10-year survival rate for head and neck cancer patients.
Kolkata doctor rape and murder: Everything you wanted to know
Protesting doctors demand better workplace safety and stricter policy measures.
AYUSH treatments to be covered under PM-JAY?
Very soon, AYUSH treatments may be covered under AB PM-JAY.
WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME
Dry eye syndrome affects lakhs of people globally, causing discomfort and vision issues. Learn how doctors must guide patients about managing it.